Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 18,718 | 16,038 | 16,079 | 17,631 | 16,413 |
| Cost of Goods | 6,143 | 6,218 | 5,440 | 5,755 | 4,939 |
| Gross Profit | 12,575 | 9,820 | 10,639 | 11,876 | 11,474 |
| Operating Expenses | 22,724 | 17,777 | 15,699 | 19,442 | 48,886 |
| Operating Income | -10,006 | -7,739 | -4,620 | -6,811 | -36,473 |
| Interest Expense | 1,476 | 3,368 | 2,041 | 2,742 | 2,518 |
| Other Income | 12,404 | 153,401 | 618 | 18,406 | 27,337 |
| Pre-tax Income | 922 | 142,294 | -6,043 | 8,853 | -11,654 |
| Income Tax | 320 | 5,132 | -646 | 26 | 0 |
| Net Income Continuous | 602 | 137,162 | -5,397 | 8,827 | -11,654 |
| Minority Interests | 1,070 | 26,789 | -1,460 | 2,977 | -27,140 |
| Net Income | $-468 | $110,373 | $-3,937 | $5,850 | $15,486 |
| EPS Basic Total Ops | -0.08 | 3.44 | -0.22 | 0.13 | 0.50 |
| EPS Basic Continuous Ops | 0.02 | 4.35 | -0.14 | 0.32 | -0.43 |
| EPS Diluted Total Ops | -0.08 | 2.82 | -0.15 | 0.11 | 0.45 |
| EPS Diluted Continuous Ops | 0.02 | 3.57 | -0.12 | 0.27 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.08 | 2.82 | -0.21 | 0.11 | -0.46 |
| EBITDA(a) | $-8,255 | $-4,585 | $-2,648 | $-4,839 | $-34,380 |